Avista Therapeutics Signs Gene Therapy Partnership with Roche for US$1 B
By Neha Madhwani
Pharma Deals Review: Vol 2022 Issue 8 (Table of Contents)
Published: 4 Aug-2022
DOI: 10.3833/pdr.v2022.i8.2712 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Avista Therapeutics has partnered with Roche to develop adeno-associated virus (AAV) gene therapy vectors for eye diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS